Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06841016 · ClinicalTrials.gov registry record · NA
Virtual Nephrologist
A NA study of Chronic Kidney Disease (CKD), sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 148
- Enrollment target
- 2
- Study locations
NCT06841016: Completed NA study of Chronic Kidney Disease (CKD), sponsored by University of Pennsylvania.
NCT06841016 is a NA study of Chronic Kidney Disease (CKD) that has completed, run by University of Pennsylvania. The registered enrollment target is 148 participants, below the 1,406-participant average among 14 other Chronic Kidney Disease (CKD) trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06841016, a NA study of Chronic Kidney Disease (CKD), has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 148 participants
- Enrollment target
- 2
- Study locations
Study Summary
To develop, pilot, and refine a virtual healthcare agent that will educate patients with advanced chronic kidney disease and their caregivers about kidney transplantation.
Primary Outcome
Assess the change in intentionally to consider/discuss getting a kidney transplant using 5-point Likert scale survey
Conditions Studied
Interventions
- OTHER Virtual Nephrologist
Study Locations (2)
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2024-03-26 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What the finished NCT06841016 record still lists
NCT06841016 is an interventional study that assigns participants to a tested intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap, below the 1,406-participant average among 14 other Chronic Kidney Disease (CKD) trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Chronic Kidney Disease (CKD) appearing as the primary indexed condition, and to 1 intervention - of which Virtual Nephrologist is the first listed.
NCT06841016 reports a single indexed study location in Pennsylvania, Tennessee.
Frequently Asked Questions
What is clinical trial NCT06841016 about?
NCT06841016 is a clinical study titled "Virtual Nephrologist". To develop, pilot, and refine a virtual healthcare agent that will educate patients with advanced chronic kidney disease and their caregivers about kidney transplantation.
What is the current status of trial NCT06841016?
This trial is currently completed. It is a NA study. The enrollment target is 148 participants. The study started on 2024-03-26. Estimated completion is 2025-12-31.
What conditions does trial NCT06841016 study?
This clinical trial studies the following conditions: Chronic Kidney Disease (CKD).
What interventions are being tested in trial NCT06841016?
The interventions under investigation include: Virtual Nephrologist (OTHER).
Who is sponsoring clinical trial NCT06841016?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06841016 being conducted?
This trial has 2 study locations across Pennsylvania, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Disease (CKD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06841016's enrollment target sits among peer trials
148 9th of 14 higher than 6 of 14 other Chronic Kidney Disease (CKD) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Kidney Disease (CKD) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exercise and Monitoring With Post-Hospitalization Muscle Atrophy to Sustain Intrinsic Capacity and Strength
RECRUITING · NA
-
An Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease
RECRUITING · NA
-
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
RECRUITING · NA
-
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
RECRUITING · NA
-
An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant
RECRUITING
-
A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic Kidney Disease (CKD) Who Need Kidney Transplantation and Are Highly Sensitized to Human Leukocyte Antigen (HLA)
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00739362 · 148 participants · Phase 2
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
- NCT03161223 · 148 participants · Phase 1
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
- NCT03858231 · 148 participants · Phase 4
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
- NCT04486352 · 148 participants · Phase 1
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI